Innovation Pharmaceuticals Inc (IPIX)

[LilyGDog]

Justfactsmam, another great post. New people to this board should do their own dd and determine for themselves whether or not IPIX/Leo are headed for greatness. The next few weeks/months could get really exciting.

Go Leo & IPIX!

TIAB...another great post! (LOL)

Quote:
"DeGrado- gimme a break already. Great career, but his skill set is not the x factor all here pretend it is. He is not a clinical trials specialist. He is not an epidemiologist...

So for the things that he knows how to do he has not been helpful so far as one can see."


...you can only speak for yourself...therefore you are really stating is:

"he has not been helpful so far as I can see"!

It would be helpful to be objective so that you could SEE...what he has likely contributed to...and has not yet been reported, nor should it be reported as a PR revealing the "DeGrado Report Card"

Non-reporting of Dr. DeGrado's activities is not = no material contribution! (a/k/a "Leo doesn't tell Bill DeGrado's assignments, therefore he has none and none exists)

Of course, you make assumptions and conclusions ...that fit Leo "failure" narrative, (and by inference "inactivity" by DeGrado).

IMO your statements are ignoring the obvious areas where he is likely making and can make material contribution...

We only have to look at what HAS TRANSPIRED AND BEEN ACCOMPLISHED since the August 26th announcement of DR. WILLIAM F. DEGRADO, A DISCOVERER OF BRILACIDIN, JOINING INNOVATION PHARMACEUTICALS AS SCIENTIFIC ADVISOR and logically assume that LEO has reached out to Dr. DeGrado...for "Review, Consultation, and Advice" involving:



September 15, 2020
LABORATORY TESTING OF BRILACIDIN FOR COVID-19 IN COMBINATION WITH REMDESIVIR REDUCES VIRAL LOAD BY NEARLY 100 PERCENT

October 2, 2020
INNOVATION PHARMACEUTICALS ANNOUNCES PRE-IND MEETING REQUEST GRANTED BY FDA FOR THE STUDY OF BRILACIDIN FOR THE TREATMENT OF COVID-19

October 30, 2020
INNOVATION PHARMACEUTICALS AND GEORGE MASON UNIVERSITY ANNOUNCE PUBLIC RELEASE OF LABORATORY TESTING RESULTS DEMONSTRATING BRILACIDIN’S COVID-19 TREATMENT POTENTIAL

November 2, 2020
INNOVATION PHARMACEUTICALS RECEIVES PRE-IND RESPONSE FROM FDA ON COVID-19 TRIAL

November 16, 2020
INNOVATION PHARMACEUTICALS ANNOUNCES OVERSEAS REGULATORY FILING SUBMITTED FOR COVID-19 CLINICAL STUDY

November 30, 2020
INNOVATION PHARMACEUTICALS COVID-19 CLINICAL TRIAL TO SUPPORT ADDITIONAL DEVELOPMENT OF BRILACIDIN AS A “PAN-CORONAVIRUS” THERAPEUTIC

December 21, 2020
FDA GRANTS IND APPROVAL FOR PHASE 2 CLINICAL TRIAL OF INNOVATION PHARMACEUTICALS’ BRILACIDIN FOR TREATING COVID-19

January 14, 2021
INNOVATION PHARMACEUTICALS’ BRILACIDIN FOR THE TREATMENT OF COVID-19 RECEIVES FDA FAST TRACK DESIGNATION

It is also illogical to assume DeGrado...is not LEO's "go-to guy" for:

1. patent filing updates,
2. new Grant applications planned or underway,
3. additional research by RBL's and other on B's potential efficacy on the entire family of pan-coronavirus
4. discussions with the additional B testing by RBLs (press release) and
5. interaction and discourse about Brilacidin as a exceptionally promising Covid-19 Therapeutic...with soon to be appointed FDA Commission, Dr. Kessler a professor also at UCSF with Dr.DeGrado

All the above ... "one" would not necessarily want public...the element of secrecy is important regarding alerting the competition. And "one" would have to be Blind not to believe DeGrado is a tremendous believer of the probability of Brilacidin being a Therapeutic success over Covid-19.

The jingle says of DeGrado's presence as an invaluable endorsement of Brilacidin:

"DeGrado... Priceless".